XTL BIOPHARMACEUTICALS-ADR (XTLB) Stock Income Statement
USA - NASDAQ:XTLB - US98386D3070 - ADR
0.9 USD
-0.01 (-1.11%)
0.873 USD
-0.03 (-3%)
| TTM (2019-6-30) | 2018 (2018-12-31) | 2017 (2017-12-31) | 2016 (2016-12-31) | 2015 (2015-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | 0 | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | 810.00K | 790.00K | 1.25M | 1.71M | 2.01M | |||
| Research and Development | 40.00K | 40.00K | 40.00K | 440.00K | 580.00K | |||
| Selling, General, and Administrative Expenses | 770.00K | 760.00K | 1.20M | 1.27M | 1.42M | |||
| Operating Income | -810.00K | -790.00K | -1.25M | -1.71M | -2.01M | |||
| Interest Income/Expense | 2.53M | 60.00K | 40.00K | 20.00K | -10.00K | |||
| Other Income/Expense | null | 3.72M | 430.00K | 0 | 10.00K | |||
| Non Recurring Items | null | 0 | 0 | -850.00K | -1.60M | |||
| Income Before Taxes | 3.10M | 2.99M | -780.00K | -2.55M | -3.62M | |||
| Income Tax | null | null | null | null | null | |||
| Net Income | 3.10M | 2.99M | -780.00K | -2.55M | -4.31M | |||
| EBITDA | null | undefined | undefined | undefined | -2.00M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.6028621076891818 | 0.581470226448598 | -0.1658891669928809 | -0.9305142611708181 | -8.170556136014808 | |||
| Non GAAP EPS | null | null | null | null | null | |||
| Statistics | ||||||||
All data in USD